Guidance for Salix Pharmaceuticals Ltd. (SLXP)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2014 | $5.20 | $6.17 | $1.40B | $1.59B | = Maintained | Details |
| 2014 | $6.46 | $5.98 | $1.60B | $1.59B | = Maintained | Details |
| Q4 2014 | $1.16 | $1.95 | $325.00M | $436.00M | = Maintained | Details |
| Q3 2013 | N/A | N/A | $238.00M | $238.42M | = Maintained | Details |
| Q2 2013 | $0.78 | $0.79 | $228.00M | $224.01M | = Maintained | Details |
| 2012 | $3.13 | $2.87 | N/A | N/A |  Raised |
Details |
| Q1 2011 | $0.00 | $0.40 | N/A | N/A | = Maintained | Details |
